Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings

@article{Atmaca2002EfficacyOC,
  title={Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings},
  author={M. Atmaca and M. Kuloğlu and E. Tezcan and A. Unal},
  journal={Human Psychopharmacology: Clinical and Experimental},
  year={2002},
  volume={17}
}
The efficacy of irreversible and reversible monoamine oxidase inhibitors (MAOIs) in the treatment of social phobia (SP) is well established. Recently, selective serotonin reuptake inhibitors (SSRIs) have been used more frequently. In the present study, the efficacy and side‐effect profile of citalopram, an SSRI, and moclobemide, the only MAOI used in Turkey, were compared. The 71 patients diagnosed with SP according to DSM‐III‐R were randomly assigned to two subgroups; citalopram (n = 36) or… Expand
Resistant social anxiety disorder response to Escitalopram
Current management of obsessive and phobic states
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
Social Anxiety Disorder
Pharmacotherapy for social anxiety disorder: a systematic review
Pharmacotherapy for social anxiety disorder (SAnD).
...
1
2
...

References

SHOWING 1-10 OF 30 REFERENCES
Placebo-controlled trial of moclobemide in social phobia.
Moclobemide in social phobia: a controlled dose-response trial.
Social phobia: long‐term treatment outcome and prediction of response - a moclobemide study
Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study.
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
...
1
2
3
...